OR7D2
gene geneOn this page
Also known as OR19-4HTPCRH03FLJ38149
Summary
OR7D2 (olfactory receptor family 7 subfamily D member 2, HGNC:8378) is a protein-coding gene on chromosome 19p13.2, encoding Olfactory receptor 7D2 (Q96RA2). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 162998 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 55 total
- MANE Select transcript:
NM_175883
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8378 |
| Approved symbol | OR7D2 |
| Name | olfactory receptor family 7 subfamily D member 2 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OR19-4, HTPCRH03, FLJ38149 |
| Ensembl gene | ENSG00000188000 |
| Ensembl biotype | protein_coding |
| Entrez | 162998 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000344248, ENST00000641288, ENST00000642043, ENST00000865598
RefSeq mRNA: 2 — MANE Select: NM_175883
NM_001386112, NM_175883
CCDS: CCDS32900
Canonical transcript exons
ENST00000641288 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003811779 | 9180698 | 9180788 |
| ENSE00003812201 | 9178979 | 9179123 |
| ENSE00003912469 | 9185769 | 9188818 |
Expression profiles
Bgee: expression breadth ubiquitous, 149 present calls, max score 76.73.
Top tissues by expression
227 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.73 | gold quality |
| skin of hip | UBERON:0001554 | 65.87 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 60.35 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 59.31 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 58.61 | gold quality |
| ganglionic eminence | UBERON:0004023 | 56.33 | gold quality |
| cortical plate | UBERON:0005343 | 55.75 | gold quality |
| lower lobe of lung | UBERON:0008949 | 54.87 | silver quality |
| oviduct epithelium | UBERON:0004804 | 54.44 | silver quality |
| buccal mucosa cell | CL:0002336 | 54.26 | gold quality |
| ventricular zone | UBERON:0003053 | 54.00 | gold quality |
| stromal cell of endometrium | CL:0002255 | 48.78 | gold quality |
| testis | UBERON:0000473 | 48.74 | gold quality |
| right testis | UBERON:0004534 | 48.24 | gold quality |
| gastrocnemius | UBERON:0001388 | 46.70 | gold quality |
| left testis | UBERON:0004533 | 46.59 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 46.37 | gold quality |
| urethra | UBERON:0000057 | 45.85 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 45.76 | gold quality |
| penis | UBERON:0000989 | 45.75 | silver quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 45.75 | silver quality |
| muscle of leg | UBERON:0001383 | 45.53 | gold quality |
| amniotic fluid | UBERON:0000173 | 45.44 | silver quality |
| synovial joint | UBERON:0002217 | 45.05 | gold quality |
| tibia | UBERON:0000979 | 45.01 | silver quality |
| esophagus squamous epithelium | UBERON:0006920 | 44.80 | silver quality |
| islet of Langerhans | UBERON:0000006 | 44.51 | gold quality |
| right lung | UBERON:0002167 | 44.51 | gold quality |
| fallopian tube | UBERON:0003889 | 43.93 | gold quality |
| upper leg skin | UBERON:0004262 | 43.91 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.73 |
| E-MTAB-6142 | no | 3.13 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200)
Protein
Protein identifiers
Olfactory receptor 7D2 — Q96RA2 (reviewed: Q96RA2)
Alternative names: HTPCRH03, Olfactory receptor 19-4, Olfactory receptor OR19-10
All UniProt accessions (1): Q96RA2
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (2): NP_001373041, NP_787079* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96RA2-F1 | 88.57 | 0.56 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 29 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr19p13, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, HMGA1_TARGET_GENES, MIR3133, MIR4511
GO Biological Process (5): regulation of DNA-templated transcription (GO:0006355), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
344 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR7D2 | C9orf43 | Q8TAL5 | 479 |
| OR7D2 | ARRDC5 | A6NEK1 | 461 |
| OR7D2 | ZNRF1 | Q8ND25 | 410 |
| OR7D2 | C17orf58 | Q2M2W7 | 401 |
| OR7D2 | HPR | P00739 | 381 |
| OR7D2 | VGLL4 | Q14135 | 380 |
| OR7D2 | SH3TC1 | Q8TE82 | 373 |
| OR7D2 | MYO5B | Q9ULV0 | 371 |
| OR7D2 | TNFRSF10D | Q9UBN6 | 365 |
| OR7D2 | OCA2 | Q04671 | 359 |
| OR7D2 | TNFRSF1B | P20333 | 353 |
| OR7D2 | NCF4 | Q15080 | 353 |
| OR7D2 | MS4A1 | P08984 | 353 |
| OR7D2 | ORM1 | P02763 | 351 |
| OR7D2 | FGF21 | Q9NSA1 | 350 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR7D2 | PELI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OR7D2 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | OR7D2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PELI2 | OR7D2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): OR7D2 (Two-hybrid)
ESM2 similar proteins: A0A2R8YED5, A6NM03, O14581, O60412, O76099, O95006, O95047, O95371, P34982, P34984, P47884, P58170, Q15619, Q15622, Q5TZ20, Q60883, Q60887, Q60891, Q6IFH4, Q7Z3T1, Q8N628, Q8NG84, Q8NG95, Q8NG98, Q8NG99, Q8NGA0, Q8NGA1, Q8NGA2, Q8NGQ5, Q8NGR9, Q8NGS1, Q8NGS2, Q8NGS3, Q8NGV0, Q8NGW1, Q8NGX1, Q8NH06, Q8NH80, Q8NHA4, Q95157
Diamond homologs: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, O76099, O95013, P0C604, P0C623, P0C645, P0DN82, P58180, Q13606, Q15615, Q60878, Q60881, Q60888, Q60893, Q6IEV9, Q6IEY1, Q6IF82, Q6UXT6, Q7TQQ0, Q8IXE1, Q8N0Y3, Q8NGA1, Q8NGA8, Q8NGB2, Q8NGB4, Q8NGB6, Q8NGB8, Q8NGB9, Q8NGC2, Q8NGC3, Q8NGC4, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD3, Q8NGD4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
55 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
44 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:9186739:GAC:G | donor_gain | 0.9100 |
| 19:9186459:G:GT | donor_gain | 0.8500 |
| 19:9186748:GTTTT:G | donor_gain | 0.7900 |
| 19:9186667:G:GT | donor_gain | 0.7400 |
| 19:9186538:G:A | acceptor_gain | 0.7100 |
| 19:9186537:T:TA | acceptor_gain | 0.6500 |
| 19:9186758:C:T | donor_gain | 0.6500 |
| 19:9186686:G:T | donor_gain | 0.6000 |
| 19:9186082:GTC:G | donor_gain | 0.5800 |
| 19:9186083:TCT:T | donor_gain | 0.5800 |
| 19:9186536:ATG:A | acceptor_gain | 0.5600 |
| 19:9186537:T:G | acceptor_gain | 0.5600 |
| 19:9186536:ATGGG:A | acceptor_gain | 0.5500 |
| 19:9186084:C:A | donor_gain | 0.5400 |
| 19:9186535:TATGG:T | acceptor_gain | 0.5200 |
| 19:9186745:G:GT | donor_gain | 0.5200 |
| 19:9186767:C:T | donor_gain | 0.5100 |
| 19:9188717:ATGTG:A | acceptor_gain | 0.5100 |
| 19:9186536:AT:A | acceptor_gain | 0.5000 |
| 19:9186752:T:TG | donor_gain | 0.5000 |
| 19:9186753:G:GG | donor_gain | 0.5000 |
| 19:9186676:G:GT | donor_gain | 0.4800 |
| 19:9186395:T:A | donor_gain | 0.4700 |
| 19:9186538:GGGA:G | acceptor_gain | 0.4400 |
| 19:9186537:TGGG:T | acceptor_gain | 0.4300 |
| 19:9185893:ACG:A | donor_gain | 0.4200 |
| 19:9186686:G:GT | donor_gain | 0.3900 |
| 19:9186086:A:G | donor_gain | 0.3800 |
| 19:9186369:C:T | donor_gain | 0.3600 |
| 19:9186460:A:T | donor_gain | 0.3500 |
AlphaMissense
2052 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:9186001:A:C | S74R | 0.902 |
| 19:9186003:C:A | S74R | 0.902 |
| 19:9186003:C:G | S74R | 0.902 |
| 19:9185815:T:C | F12L | 0.876 |
| 19:9185817:T:A | F12L | 0.876 |
| 19:9185817:T:G | F12L | 0.876 |
| 19:9186532:T:C | F251L | 0.870 |
| 19:9186534:T:A | F251L | 0.870 |
| 19:9186534:T:G | F251L | 0.870 |
| 19:9186135:G:A | M118I | 0.861 |
| 19:9186135:G:C | M118I | 0.861 |
| 19:9186135:G:T | M118I | 0.861 |
| 19:9186652:A:C | S291R | 0.846 |
| 19:9186654:C:A | S291R | 0.846 |
| 19:9186654:C:G | S291R | 0.846 |
| 19:9186146:G:C | R122P | 0.813 |
| 19:9185995:T:C | C72R | 0.796 |
| 19:9186148:T:C | F123L | 0.793 |
| 19:9186150:T:A | F123L | 0.793 |
| 19:9186150:T:G | F123L | 0.793 |
| 19:9185872:T:C | F31L | 0.791 |
| 19:9185874:C:A | F31L | 0.791 |
| 19:9185874:C:G | F31L | 0.791 |
| 19:9186313:T:C | F178L | 0.777 |
| 19:9186315:C:A | F178L | 0.777 |
| 19:9186315:C:G | F178L | 0.777 |
| 19:9186283:T:C | F168L | 0.771 |
| 19:9186285:C:A | F168L | 0.771 |
| 19:9186285:C:G | F168L | 0.771 |
| 19:9185907:C:A | N42K | 0.760 |
dbSNP variants (sampled 300 via entrez): RS1000216714 (19:9179099 C>A,G), RS1000530898 (19:9182398 G>A), RS1000664221 (19:9183079 C>G,T), RS1000670494 (19:9183168 A>C), RS1000762562 (19:9177495 A>G), RS1001034853 (19:9182812 C>A,T), RS1001056235 (19:9188041 A>G), RS1001125083 (19:9188035 G>A,C,T), RS1001461364 (19:9177002 C>T), RS1001827775 (19:9177847 T>C), RS1001929661 (19:9187346 C>A,T), RS1001957551 (19:9187608 G>A), RS1002149704 (19:9183641 A>G), RS1002223456 (19:9183353 C>T), RS1002546169 (19:9182582 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| pentabromodiphenyl ether | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.